The abstract: "The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients" from Dr. Tim Rattay, et al, has been confirmed as poster at NCRI Liverpool and also for poster presentation at the SABCS in texas.
The National Cancer Research Institute (NCRI) is a UK-wide partnership between research funders working together to make faster progress against cancer. The NCRI Cancer Conference showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations. The Conference takes place in Liverpool on 6-9 Novembre 2016. It is the UK’s premier annual cancer research meeting and attracts around 2000 delegates each year. For more information visit the website: